Medinet CoTSE:2370 41 Quick Ratio is 14.07 as of Mar. 2026, which is 14% above its 10-year median of 12.30. GuruFocus rates TSE:2370 with a GF Score™ of 41/100 and a GF Value™ of 円41.74 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,411 Biotechnology companies, Medinet Co ranks better than 86.11% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Medinet Co's quick ratio for the quarter that ended in Mar. 2026 was 14.07.
Medinet Co has a quick ratio of 14.07. It generally indicates good short-term financial strength.
The historical rank and industry rank for Medinet Co's Quick Ratio or its related term are showing as below:
TSE:2370'
s Quick Ratio Range Over the Past 10 Years
Min: 2.73 Med: 12.3 Max: 20.6
Current: 14.07
During the past 13 years, Medinet Co's highest Quick Ratio was 20.60. The lowest was 2.73. And the median was 12.30.
TSE:2370's Quick Ratio is ranked better than 86.11% of 1411
companies
in the Biotechnology industry
Industry Median: 3.59
vs TSE:2370: 14.07
Medinet Co (TSE:2370) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Medinet Co Quick Ratio Related Terms
Medinet Co Quick Ratio Historical Data
* Premium members only.
The historical data trend for Medinet Co's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2370 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Medinet Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinet Co Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medinet Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Medinet Co's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Medinet Co's Quick Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinet Co (TSE:2370) has a Quick Ratio of 14.07 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Medinet Co and its competitors. This is 14% above median its historical median of 12.30. Over the past decade, Medinet Co's Quick Ratio has ranged from 2.73 to 20.60. According to the industry distribution chart, Medinet Co ranks #196 out of 1411 companies in the Biotechnology industry, placing it in the top 13.9%.
Is Medinet Co's Quick Ratio too high?
Medinet Co's current Quick Ratio of 14.07 is 14% above median its 10-year median of 12.30. Over the past 10 years, this metric has ranged from a low of 2.73 to a high of 20.60. The Biotechnology industry median Quick Ratio is 3.59. Medinet Co's value of 14.07 is 291.9% above this industry median. Based on the distribution chart, Medinet Co ranks #196 out of 1411 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Medinet Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medinet Co ranks #196 out of 1411 companies for Quick Ratio. This places Medinet Co in the top 14% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 3.59. Medinet Co's value of 14.07 is 291.9% above this benchmark. Historically, Medinet Co's own Quick Ratio has ranged from 2.73 to 20.60 over the past decade. While the company's 10-year median is 12.30 vs. the industry median of 3.59, Medinet Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.59, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinet Co's current Quick Ratio of 14.07 is 291.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Medinet Co and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinet Co's current Quick Ratio is 14.07, which is 14% above median its own 10-year median of 12.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.74, compared to a current price of 円25.00 — trading 40.1% below its estimated fair value. The current Quick Ratio is 14.07, which is 14% above median its 10-year median of 12.30 and 291.9% above the Biotechnology industry median of 3.59. Medinet Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current Quick Ratio is 14.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinet Co (TSE:2370) Overvalued in 2026?
Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued.
The current stock price of 円25.00 is trading 40.1% below its estimated GF Value™ of 円41.74.
GuruFocus considers Medinet Co to be Possible Value Trap.
Key valuation signals for TSE:2370:
Quick Ratio: 14.07 (14% above median its 10-year median of 12.30)
GF Value™: 円41.74 vs. price of 円25.00 (40.1% below fair value)
Industry Position: 291.9% above the Biotechnology median (#196 of 1411)
No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
41GF Score
Get the complete analysis for TSE:2370
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2370 has been successfully added to your 
